Skip to main content

Armada Hoffler Reports Fourth Quarter 2025 Results

GAAP Net Loss of $0.01 Per Diluted Share for the Fourth Quarterand $0.08 per Diluted Share for the Full Year Normalized FFO of $0.29 Per Diluted Share for the Fourth Quarter and $1.08 per Diluted Share for the Full Year Office Same Store NOI Growth of 10.4% (GAAP)Positive Office Renewal Spreads of 9.1% (GAAP) and 2.5% (Cash) Positive Retail Renewal Spreads of 15.3% (GAAP) and 10.1% (Cash) VIRGINIA BEACH, Va., Feb. 16, 2026 (GLOBE NEWSWIRE) — Armada Hoffler Properties, Inc. (NYSE: AHH) today announced its results for the quarter ended December 31, 2025 and provided an update on current events and earnings guidance. Fourth Quarter and Recent Highlights:Net loss attributable to common stockholders and OP Unitholders of $1.0 million, or $0.01 per diluted share, compared to net income attributable to common stockholders and OP Unitholders...

Continue reading

Aspo Plc’s Financial Statements Release, January 1 – December 31, 2025: A year with significant profit improvement in a challenging market

Aspo Plc Financial Statements Release February 16, 2026, at 9.00 EET Aspo Plc’s Financial Statements Release, January 1 – December 31, 2025: A year with significant profit improvement in a challenging market This is a summary of the Financial Statements Release January 1 – December 31, 2025 of Aspo Plc. The complete report is attached to this release and available at aspo.com. October–December 2025Net sales, Group total was EUR 158.0 (159.8) million Net sales from continuing operations decreased to EUR 119.3 (124.5) million Comparable EBITA, Group total grew to EUR 8.9 (8.0) million, 5.7% (5.0%) of net salesESL Shipping EUR 3.8 (4.3) million Telko EUR 4.4 (3.9) million Discontinued operation EUR 2.0 (1.1) million Other operations EUR -1.2 (-1.2) millionEBITA, Group total was EUR 16.2 (8.1) million. EBITA of ESL Shipping was EUR...

Continue reading

Leishen Energy Holding Co., Ltd. Announced Fiscal Year 2025 Financial Results Highlighting Strong Operating Cash Flow and Low Financial Leverage

BEIJING, Feb. 15, 2026 (GLOBE NEWSWIRE) — Leishen Energy Holding Co., Ltd. (“Leishen Energy,” the “Company”) (Nasdaq: LSE) announced its fiscal year 2025 financial results on January 30, 2026, reflecting a transition period: core operating performance weakened, but the Company strengthened its financial foundation through the IPO, reduced leverage, and improved liquidity. The Company’s cash position and low debt levels provide flexibility to address operational challenges, while continued improvements in asset quality help mitigate financial risks. Fiscal Year 2025 Financial Highlights Total revenues declined from USD $63.5 million to USD $48.3 million due to the economic downturn, particularly the overall sluggishness in the oil and gas market, coupled with customers’ cost pressures, weaker market demand, and the impact of the...

Continue reading

Armlogi Holding Corp. Announces Second Quarter and First Half of Fiscal Year 2026 Results

WALNUT, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) — Armlogi Holding Corp. (“Armlogi” or the “Company”) (Nasdaq: BTOC), a U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions related to warehouse management and order fulfillment, today announced financial results for its fiscal 2026 second quarter and six-month period ended December 31, 2025. Financial Results for the Three Months Ending December 31, 2025:Total revenue increased 0.8% to $51.5 million for the three months ended December 31, 2025, compared to $51.1 million in the prior-year period.Costs of services increased to $52.3 million for the three months ended December 31, 2025, resulting in a gross loss of $0.8 million, compared to a gross profit of $0.5 million in the prior year period. Gross margin declined...

Continue reading

ThreeD Capital Inc. Releases Results For the Three and Six Months Ended December 31, 2025

TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQX:IDKFF) a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce its unaudited results as at and for the three and six months ended December 31, 2025. As at December 31, 2025, the Company had cash, investments and digital assets of $23.4 million. As at December 31, 2025, net asset value per share was $0.27 as compared to $0.40 as at June 30, 2025. (See “Use of Non-GAAP Financial Measures” elsewhere) Financial Highlights for the three and six months ending December 31, 2025 with comparatives:Operating Results Three months ended December 31, Six months ended December 31,    2025     2024     2025     2024  Net...

Continue reading

Natural Alternatives International, Inc. Announces 2026 Q2 and YTD Results

CARLSBAD, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) — Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $2.6 million, or $0.42 per diluted share, on net sales of $34.8 million for the second quarter of fiscal year 2026 compared to a net loss of $2.2 million, or $0.37 per diluted share, in the second quarter of the prior fiscal year. Net sales during the three months ended December 31, 2025, increased $0.7 million, or 2%, to $34.8 million as compared to $34.1 million recorded in the comparable prior year period. During the same period, private-label contract manufacturing sales increased 2% to $32.8 million. Private-label contract manufacturing sales increased primarily due to increased orders...

Continue reading

Edesa Biotech Reports Fiscal 1st Quarter 2026 Results

TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) — Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three months ended December 31, 2025 and provided an update on its business. During the first quarter, Edesa progressed manufacturing of its dermatology drug candidate, EB06 (an anti-CXCL10 monoclonal antibody), and placebo for an upcoming Phase 2 study in moderate-to-severe nonsegmental vitiligo. The company anticipates recruitment will begin midyear 2026, subject to regulatory approvals. In its respiratory program, Edesa reported that it is evaluating subgroup data for additional efficacy signals among subjects with certain comorbidities following positive results from a Phase 3 study of...

Continue reading

Farmer Brothers Coffee Reports Second Quarter Fiscal 2026 Financial Results

FORT WORTH, Texas, Feb. 13, 2026 (GLOBE NEWSWIRE) — Farmer Brothers Coffee Co. (NASDAQ: FARM), a leading roaster, wholesaler and distributor of coffee, tea and allied products, announced today its second quarter fiscal 2026 financial results for the period ended Dec. 31, 2025. The company filed its Form 10-Q, which will be posted on the Investor Relations section of its website after the close of market Friday, Feb. 13. “As expected, the second quarter was a challenging one for Farmer Brothers. We, however, continued to see year-over-year improvement in selling and general and administrative cost and our gross margin remained above 35%, where we expect it to be for the remainder of fiscal 2026,” said President and Chief Executive Officer John Moore. “Despite pressures related to higher cost of goods sold and current micro and macroeconomic...

Continue reading

Westwood Holdings Group Reports Fourth Quarter and Full Year 2025 Results

Our expanded ETF platform now exceeds $200 million in AUMSuccessful year-end close of WES II with over $300 million in commitmentsManaged Investment Solutions team secured its first institutional client DALLAS, Feb. 13, 2026 (GLOBE NEWSWIRE) — Westwood Holdings Group, Inc. (NYSE: WHG) today reported fourth quarter and fiscal year 2025 earnings. Significant items include:Investment strategies beating their primary benchmarks in the fourth quarter included Enhanced Balanced, Total Return, Income Opportunity, Multi-Asset Income, Alternative Income, MLP & Energy Infrastructure, Westwood Salient Enhanced Midstream Income ETF and Westwood Salient Enhanced Energy Income ETF. Income Opportunity posted a top quartile ranking vs. peers and Total Return posted a top decile ranking in the quarter. Quarterly revenues totaled $27.1 million...

Continue reading

SRX Health Solutions Inc. Announces Fiscal First Quarter 2026 Results for Quarter Ended December 31, 2025

Executed Definitive Agreement to Acquire EMJ Crypto Technologies (“EMJX”), a “Gen 2” Digital-Asset Treasury Platform, Anticipated to Close in first half of Calendar 2026  Strengthened Balance Sheet, with $13.1 Million in Cash at Quarter End During and Subsequent to Quarter, Deployed $18 Million Into Bitcoin and Ethereum as part of Digital Treasury Strategy NORTH PALM BEACH, Fla., Feb. 13, 2026 (GLOBE NEWSWIRE) — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company” or “SRXH“), a pet health and wellness company, today announced its financial results for the fiscal first quarter 2026 for the three-month period ended December 31, 2025. “Q1 FY26 marked a pivotal reset for the Company,” stated Kent Cunningham, CEO of SRXH. “We exited prior balance sheet restructuring with materially improved liquidity...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.